Zivo Bioscience's market cap is currently ―. The company's EPS TTM is $-4.585; its P/E ratio is -1.71; Zivo Bioscience is scheduled to report earnings on April 23, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 11.80K	$ 4.05K	-	-	$ 0.00
Gross Profit	$ 4.13K	$ 3.35K	-	$ 1.16M	-
EBIT	$ -1.79M	$ -1.82M	$ -1.97M	$ -3.16M	$ -2.00M
EBITDA	$ -1.38M	$ -1.05M	$ -2.10M	$ -3.23M	$ -2.00M
Net Income Common Stockholders	$ -1.82M	$ -2.07M	$ -1.97M	$ -3.16M	$ -2.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 21.07K	$ 208.60K	$ 1.80M	$ 3.39M
Total Assets	$ 2.10M	$ 710.33K	$ 1.13M	$ 2.12M	$ 3.97M
Total Debt	$ 1.50M	$ 1.51M	$ 960.42K	$ 445.18K	$ 604.32K
Net Debt	$ 1.50M	$ 1.49M	$ 751.82K	$ -1.35M	$ -2.78M
Total Liabilities	$ 3.20M	$ 3.86M	$ 2.87M	$ 2.13M	$ 2.45M
Stockholders Equity	$ -1.09M	$ -3.14M	$ -1.74M	$ -10.62K	$ 1.52M
Cash Flow	-
Free Cash Flow	$ -1.97M	$ -985.67K	$ -2.13M	$ -1.45M	$ -1.49M
Operating Cash Flow	$ -1.97M	$ -985.67K	$ -2.13M	$ -1.45M	$ -1.49M
Investing Cash Flow	-	-	-	-	$ 0.00
Financing Cash Flow	$ 3.43M	$ 798.13K	$ 538.31K	$ -139.69K	$ -209.53K

Currency in USD

Zivo Bioscience Earnings and Revenue History

Income Statement >

Zivo Bioscience Debt to Assets

Balance Sheet >

Zivo Bioscience Cash Flow

Cash Flow >

Zivo Bioscience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing